Drugs / anti-CLL1 CART
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04884984 | Jul 2017 → Dec 2022 | acute myeloid leukemia | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-CLL1 CART | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04884984 ↗ |
| Modality | Cell therapy | “anti-CLL1 CAR T cells” NCT04884984 ↗ |
| Route | Intravenous | “Split intravenous infusion of anti-CLL1 CAR T cells” NCT04884984 ↗ |